[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356373-105":59,"doc-detail-356373-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-validation-of-an-ai-assisted-predictive-model-integrating-r2-mapping-and-clinical-indicators-for-clinically-significant-prostate-cancer-read-online-free","Development and Validation of an AI-Assisted Predictive Model Integrating R2* Mapping and Clinical Indicators for Clinically Significant Prostate Cancer - read online free","","Limited evidence supports how AI-assisted S-PI-RADS v2.1, when combined with quantitative MRI parameters, performs for detecting clinically significant prostate cancer (csPCa). A prospective study developed and validated a nomogram integrating AI-assisted S-PI-RADS v2.1 (biparametric MRI) and R2* mapping. Among 345 patients, age, BMI, PSA, free PSA, prostate volume, S-PI-RADS score, and R2* were analyzed via logistic regression, then evaluated with AUC, calibration, DCA, and DeLong tests. BMI, PSA ≥10 ng/mL, PV, S-PI-RADS 4–5, and R2* were independent predictors, and the full model outperformed baseline with AUC 0.915 and robust internal validation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-an-ai-assisted-predictive-model-integrating-r2-mapping-and-clinical-indicators-for-clinically-significant-prostate-cancer-read-online-free/356373/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-an-ai-assisted-predictive-model-integrating-r2-mapping-and-clinical-indicators-for-clinically-significant-prostate-cancer-read-online-free/356373.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of the study?","Question",{"text":112,"@type":113},"To develop and validate a nomogram that predicts clinically significant prostate cancer by integrating AI-assisted S-PI-RADS v2.1 (based on biparametric MRI) and R2* mapping.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data and predictors were used to build the model?",{"text":117,"@type":113},"Clinical indicators (age, BMI, PSA, free PSA) and imaging parameters (prostate volume, S-PI-RADS score, R2*) were analyzed, and independent predictors were identified using logistic regression.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the full AI-enhanced nomogram perform compared with the baseline model?",{"text":121,"@type":113},"The full model showed better discrimination (AUC = 0.915) than the baseline model (AUC = 0.891), with 85.2% sensitivity and 80.9% specificity, and robust internal validation (C-index = 0.884).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356373,1790319281,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer Medicine  \n|  RESEARCH ARTICLE  OPEN ACCESS \u003Cbr>Development and Validation of an AI-Assisted Predictive Model Integrating R2* Mapping and Clinical Indicators for Clinically Significant Prostate Cancer\u003Cbr>Xin Li  | Yonggui Shi  | Jing Fang  | Rong Zhang  | Xiaojing He  | Guangyong Ai  Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China\u003Cbr>Correspondence: Xiaojing He ([he_xiaojing@hospital.cqmu.edu.cn](he_xiaojing@hospital.cqmu.edu.cn)) | Guangyong Ai ([303701@hospital.cqmu.edu.cn](303701@hospital.cqmu.edu.cn))\u003Cbr>Received: 14 August 2025 | Revised: 3 February 2026 | Accepted: 9 February 2026\u003Cbr>Keywords: artificial intelligence | biparameter | nomogram | prostate cancer | prostate imaging reporting and data system | R2* mapping |  |\n| --- | --- |\n| ABSTRACT\u003Cbr>Background: Limited evidence exists on the diagnostic performance of Artificial Intelligence (AI)-assisted Simplified Prostate Imaging Reporting and Data System version 2.1 (S-PI-RADS v2.1) combined with quantitative MRI parameters for detecting clinically significant prostate cancer (csPCa) .\u003Cbr>Purpose: To develop and validate a nomogram incorporating AI-assisted S-PI-RADS v2.1 (based on biparametric MRI [bpMRI]) and R2* mapping for csPCa prediction.\u003Cbr>Methods: This prospective study enrolled 345 patients grouped by pathology: non-csPCa with benign prostatic hyperplasia (n = 230) and csPCa (n = 115) . Clinical (age, body mass index [BMI], prostate-specific antigen [PSA], free PSA) and imaging parameters (prostate volume [PV], S-PI-RADS score, R2*) were analyzed. Independent predictors were identified via logistic regression. A nomogram was developed using R software with the DynNom package (Version 2.0) and validated (1000 bootstrap iterations), with performance assessed by area under the curve (AUC), calibration, decision curve analysis (DCA), and DeLong test (p \u003C 0.05 significant) .\u003Cbr>Results: Independent csPCa predictors included BMI, PSA ≥10 ng/mL, PV, S-PI-RADS scores 4–5, and R2* (all p \u003C 0.05) . The full model (BMI + PSA + PV + S-PI-RADS + R2*) showed superior discrimination (AUC = 0.915) versus the baseline model (AUC = 0.891, p = 0.008), with 85.2% sensitivity and 80.9% specificity. Internal validation was robust (C-index = 0.884) . DCA confirmed clinical utility. An interactive nomogram was deployed ([https://aiguangyong2025.shinyapps.io/dynnomapp/](https://aiguangyong2025.shinyapps.io/dynnomapp/)). Conclusion: The AI-enhanced nomogram integrating clinical and multiparametric MRI data accurately predicts csPCa noninvasively, with R2* significantly improving performance. This tool facilitates personalized clinical decision-making. |  |\n| 1 | Introduction | have a poor prognosis. Thus, early diagnosis of csPCa is of great clinical significance. In csPCa, glandular structure destruction, |\n| Prostate cancer (PCa) is one of the most common malignancies | increased cellularity, and reduced extracellular space occur. It |\n| and the second leading cause of cancer-related death in men | is highly aggressive, fast-progressing, and has a poor prognosis, |\n| [1] . The treatment and prognosis of PCa vary widely to its his- | requiring active clinical intervention. In contrast, non-clinically |\n| tological subtypes. Tumors with high metastatic potential often | significant (ncsPCa), including benign prostatic hyperplasia, is |\n| Xin Li and Yonggui Shi contributed equally to the work as co-first authors.\u003Cbr>Xiaojing He and Guangyong Ai contributed equally to the work as co-corresponding authors. |  |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd. |  |\n\nCancer Medicine, 2026; 15:e71656 1 of 11  \n[https://doi.org/10.1002/cam4.71656](https://doi.org/10.1002/cam4.71656)  \nwell-different","cbCaie4EnPmyffbj","https://ap.wps.com/l/cbCaie4EnPmyffbj","pdf",1416831,11,"English","# Introduction\n## Clinical significance and diagnostic need\n## AI and quantitative MRI background\n## S-PI-RADS v2.1 and bp-MRI rationale","[{\"question\":\"What was the purpose of the study?\",\"answer\":\"To develop and validate a nomogram that predicts clinically significant prostate cancer by integrating AI-assisted S-PI-RADS v2.1 (based on biparametric MRI) and R2* mapping.\"},{\"question\":\"What data and predictors were used to build the model?\",\"answer\":\"Clinical indicators (age, BMI, PSA, free PSA) and imaging parameters (prostate volume, S-PI-RADS score, R2*) were analyzed, and independent predictors were identified using logistic regression.\"},{\"question\":\"How did the full AI-enhanced nomogram perform compared with the baseline model?\",\"answer\":\"The full model showed better discrimination (AUC = 0.915) than the baseline model (AUC = 0.891), with 85.2% sensitivity and 80.9% specificity, and robust internal validation (C-index = 0.884).\"}]","Development and Validation of an AI-Assisted Predictive Model Integrating R2* Mapping and Clinical Indicators for Clinically Significant Prostate Cancer - read online free | PDF",1790125071,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a35a0714e3237cfe5d63d8191906f29.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ac11cd69d8af7f3a8a261e27471ecfa.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d386d62d590bcbaa0667e2f0ffb0a58c.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bde83a3cdda97e64c969e3cbe7c91480.webp",980,1287]